WeVote
Log In

Bill

Bill

SB 170

Relating to authorizing the possession, use, cultivation, distribution, delivery, sale, and research of medical cannabis for medical use by patients with certain medical conditions and the licensing of medical cannabis organizations; authorizing fees.

89th Legislature (2025) Introduced by José Menéndez

Texas medical cannabis bill authorizes patient possession, cultivation, and licensed commercial distribution for qualified medical conditions while establishing regulatory framework and licensing fees.

Referred to Health & Human Services
#crimes--drugs(i0185) #governor(i0375) #health&humanservicescommission(v0177) #health--otherdiseases&medicalconditions(i0383) #marihuana(s3105) #medicalcannabisresearchact(po881) #medicalcannabisresearchadvisoryboard(vc6y5) #medicine&prescriptiondrugs(s7338) #occupationalregulation--othertrades&professions(i0541) #parentalrights(s0095) #physicians(s1282) #publicsafety #departmentof(v0251) #statehealthservices #departmentof(v0463)
0
WeVote Research Nonpartisan
Bill Summary · SB 170

Legislative bill overview

SB 170 would establish a medical cannabis program in Texas, authorizing qualified patients with specific medical conditions to legally possess, use, and cultivate cannabis for therapeutic purposes. The bill would also create a licensing framework for medical cannabis organizations to cultivate, distribute, and sell these products, along with provisions for research and regulatory fees.

Why is this important

Texas currently has no comprehensive medical cannabis program, making this legislation potentially significant for patients with chronic conditions seeking alternative treatments. The bill would generate state revenue through licensing fees while creating a new regulatory structure and legal framework for an industry that currently operates in legal limbo in the state.

Potential points of contention

  • Scope of qualifying conditions: The bill references "certain medical conditions" but doesn't specify which conditions qualify, raising questions about access equity and lobbying over the final list
  • Federal-state legal conflict: Cannabis remains federally illegal under Schedule I, creating potential conflicts with federal law enforcement and banking regulations that could complicate implementation
  • Regulatory framework details: The bill authorizes fees and licensing but doesn't provide specifics on how many licenses will be issued, pricing, or whether vertically-integrated monopolies or competitive markets are preferred

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.